Published research on these studies documented outcomes from approximately 900 adult participants, predominantly individuals classified as clinically obese, though one trial included healthy non-obese volunteers
Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc
Store at 20 to 25C (68 to 77F)
Published references involving AOD-9604 limit its investigation to non-clinical research settings, including peptide structure analysis, molecular interaction studies, analytical method development, and experimental modeling related to lipid-associated biochemical pathways
Most therapeutic protocols recommend cycles of 8-12 weeks, followed by a 4-week break to maintain sensitivity